Three Coastal Orthopedics’ physicians, Douglas Constant, M.D., a pain management specialist, Gennady Gekht, M.D., a pain management specialist and Steven J. Schafer, M.D, a sports medicine specialist, were recently named to 2018 Castle Connolly Top Doctors.
Coastal Orthopedics’ Physicians Make National Top Doc List

Each year Castle Connolly Medical Ltd. compiles their national list of top doctors from almost 100,000 nominations. This is the third year Dr. Constant has been recognized, the fourth year for Dr. Gekht and the sixth year for Dr. Schafer.
“Coastal Orthopedics is committed to providing exemplary patient care and the Castle Connolly Top Doctors distinction is a testament to the high quality of our physicians,” Paige LeMay, chief executive officer of Coastal Orthopedics said.
“Dr. Schafer, Dr. Gekht and Dr. Constant represent the best of the best in American physicians. We’re proud they are members of the Coastal team.”
Those doctors that make the Castle Connolly Top Doctors list are nominated by their peers in an extensive survey process. More than 50,000 physicians and healthcare executives are involved in the nomination process, and then the Castle Connolly physician-led research team screens these physicians’ medical education, training, hospital appointments, disciplinary histories as well as other information. The doctors deemed the best in their specialties and in their communities make the top doctor list for that year.
Coastal Orthopedics located in Bradenton, Florida, offers comprehensive orthopedic services and has on staff 17 orthopedic surgeons and pain management physicians who have hospital affiliations with Blake Medical Center, Manatee Memorial Hospital and Lakewood Ranch Medical Center. Learn more about Coast Orthopedics here.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.